-
Apply online now: https://karriere.klinikum.uni-heidelberg.de/index.php?ac=application&jobad_id=25541 PhD position - Functional and molecular characterization of AI-based morphological predictors
-
PhD position (f/m/d) “How to regulate the duration of mitosis and control cell fate decisions” Centre for Molecular Biology (ZMBH) Heidelberg University, Germany We are seeking highly motivated PhD
-
resistance and relapse. Our ultimate goal is to develop new anti-leukemic therapies. We are searching for a highly motivated and dedicated student with a strong background in molecular biology and/or cell
-
“Cellular Plasticity in Myeloid Malignancies: From Mechanisms to Therapies”. In this CRC we will focus on myeloid malignancies as a model to dissect the various molecular mechanisms that enable and regulate
-
Malignancies: From Mechanisms to Therapies”. In this CRC we will focus on myeloid malignancies as a model to dissect the various molecular mechanisms that enable and regulate cancer cell plasticity in AML. Our
-
), EMBL Heidelberg and the Hopp-Children’s Cancer Center (KiTZ). These include Prof. Andreas Kulozik and Prof. Matthias Hentze as part of the Molecular Medicine Partnership Unit (MMPU) research group
-
data integration, cancer systems biology, and single-cell analysis, with strong links to clinical and translational oncology. Our work is based in the dynamic research environment of Heidelberg
-
fellows (f/m/d) The place of employment is Heidelberg, in the interdisciplinary Research Training Group (RTG) 2840 entitled “Ambivalent Enmity: Dynamics of Antagonism in Europe, Asia and the Middle East